VentureBeat January 14, 2025
Dean Takahashi

Cerebras Systems has teamed with Mayo Clinic to create an AI genomic foundation model that predicts the best medical treatments for people with reheumatoid arthritis.

It could also be useful in predicting the best treatment for people with cancer and cardiovascular disease, said Andrew Feldman, CEO of Cerebras Systems, in an interview with GamesBeat.

Mayo Clinic, in collaboration with Cerebras Systems, announced significant progress in developing artificial intelligence tools to advance patient care, today at the JP Morgan Healthcare Conference in San Francisco.

As part of Mayo Clinic’s commitment to transforming healthcare, the institution has led the development of a world-class genomic foundation model, designed to support physicians and patients.

Like Nvidia and other semiconductor companies, Cerebras is focused on...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Health System / Hospital, Provider, Technology
How HP sees the era of the AI PC | Alex Cho
Who Wins If The New Biden AI Export Rules Stand?
AI's role in stroke care at Orlando Health, 2 years in
WindRose Invests in CIVIE, an AI-Powered Radiology Solutions Provider
Arcadia Launches AI-Powered Precision Medicine Solution

Share This Article